Solrikitug

DB19301InvestigationalProtein Based Therapies

Solrikitug is under investigation in clinical trial NCT06496607 (A Study to Evaluate Solriktug in Adult Participants With Asthma).

Mechanism: Pharmacologically active on Cytokine receptor-like factor 2
Curator reviewed
Code names: NSI-8226

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Solrikitug, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.